- The Richter Gedeon drugs producer in Hungary is to issue new sharesto a nominal value of 1 billion forint ($5.8 million), while the State Privatization and Holding Company will sell shares in the company worth a nominal 1.8 million forint, according to MTI Econews. Most shares will be offered via public subscription, but 200,000 shares with a nominal value of 200 million forint will be offered to private investors in Hungary. These investors will be able to pay half the share price immediately and the remainder within a year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze